What is it about?
This clinical trial examined the effectiveness of cognitive therapy (CT) in patients with social anxiety disorder (SAD) who remain symptomatic following antidepressants treatment.
Featured Image
Photo by Miguel Henriques on Unsplash
Why is it important?
Antidepressants are a commonly used first-choice treatment for SAD, but a significant proportion of patients fail to remit following antidepressants. Therefore, more work is required to garner evidence of next-step treatment options for SADs who have been ineffectively treated with antidepressants. This is the first clinical trial demonstrated that in refractory SAD patients, CT is an effective treatment over 16 weeks in reducing social anxiety and related symptoms. Findings of the study will contribute to updating treatment guideline for SAD.
Perspectives
Based on this finding, Japanese national health insurance has started to cover CT for SAD from Apr. 2016.
Dr Naoki Yoshinaga
University of Miyazaki
Read the Original
This page is a summary of: Cognitive Behavioral Therapy for Patients with Social Anxiety Disorder Who Remain Symptomatic following Antidepressant Treatment: A Randomized, Assessor-Blinded, Controlled Trial, Psychotherapy and Psychosomatics, January 2016, Karger Publishers,
DOI: 10.1159/000444221.
You can read the full text:
Resources
Contributors
The following have contributed to this page
